“Compound 19” is a selective brain-penetrant inhibitor of the ceramide galactosyltransferase UGT8, intended for use in substrate reduction therapy for rare lysosomal storage disorders. The compound has good oral exposure…
Home > “Compound 19”
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.